Related references
Note: Only part of the references are listed.Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics
Kyoung-Ho Song et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping
Aisling R. Caffrey et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
Systematic Review and Meta-analysis of the Safety of Antistaphylococcal Penicillins Compared to Cefazolin
Khalid Eljaaly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia
Joseph P. Rindone et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea
S. Lee et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia
J. S. Davis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins
Monique R. Bidell et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Association of Higher Daptomycin Dose (7mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia
Tristan T. Timbrook et al.
PHARMACOTHERAPY (2018)
Clinical Outcomes with Penicillin Versus Alternative β-Lactams in the Treatment of Penicillin-Susceptible Staphylococcus aureus Bacteremia
Megan D. Shah et al.
PHARMACOTHERAPY (2018)
Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
Marguerite L. Monogue et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2018)
A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia in a Tertiary Care VA Medical Center
Dustin R Carr et al.
Open Forum Infectious Diseases (2018)
The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
William R. Miller et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins
Julius Li et al.
PHARMACOTHERAPY (2017)
Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study
Jennifer S. McDanel et al.
CLINICAL INFECTIOUS DISEASES (2017)
The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
Lauren K. Flynt et al.
INFECTIOUS DISEASES AND THERAPY (2017)
Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia
Aisling R. Caffrey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Adverse Events Lead to Drug Discontinuation More Commonly among Patients Who Receive Nafcillin than among Those Who Receive Oxacillin
J. Alexander Viehman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center
S. Pollett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013
S. S. Richter et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Comparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective Study
Erik Forsblom et al.
PLOS ONE (2016)
Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
Sonia N. Rao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections Among 122 Hospitals
Jennifer S. McDanel et al.
CLINICAL INFECTIOUS DISEASES (2015)
Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study
Anthony D. Bai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Comparative outcomes of beta-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches
Boeun Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus
Julius Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Comparative Evaluation of the Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections in the Outpatient Setting
Ilan Youngster et al.
CLINICAL INFECTIOUS DISEASES (2014)
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study
Jon Bjarke Rasmussen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible staphylococcal aureus (MSSA) bloodstream infections
Ursula C. Patel et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2014)
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted casecontrol and cohort analysis
Jette Lindbjerg Nissen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
Shinwon Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
Marin L. Schweizer et al.
BMC INFECTIOUS DISEASES (2011)
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
M. Paul et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure
Esteban C. Nannini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Staphylococcus aureus Bloodstream Infections: Definitions and Treatment
G. Ralph Corey
CLINICAL INFECTIOUS DISEASES (2009)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment:: a prospective and randomized clinical trial of 381 patients
E Ruotsalainen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection
J Schrenzel et al.
CLINICAL INFECTIOUS DISEASES (2004)
Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: Revisiting the issue
EC Nannini et al.
CLINICAL INFECTIOUS DISEASES (2003)
Share Paper
